SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-17-001890
Filing Date
2017-02-24
Accepted
2017-02-24 16:06:22
Documents
67
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm 10-K 1029263
2 ex21-1.htm EX-21.1 9428
3 ex23-1.htm EX-23.1 5309
4 ex31-1.htm EX-31.1 20132
5 ex31-2.htm EX-31.2 20597
6 ex32-1.htm EX-32.1 8319
7 ex32-2.htm EX-32.2 8350
  Complete submission text file 0001493152-17-001890.txt   4345528

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE FILE prph-20161231.xml EX-101.INS 670867
9 XBRL SCHEMA FILE prph-20161231.xsd EX-101.SCH 43734
10 XBRL CALCULATION FILE prph-20161231_cal.xml EX-101.CAL 64651
11 XBRL DEFINITION FILE prph-20161231_def.xml EX-101.DEF 157169
12 XBRL LABEL FILE prph-20161231_lab.xml EX-101.LAB 343295
13 XBRL PRESENTATION FILE prph-20161231_pre.xml EX-101.PRE 256874
Mailing Address 621 N. SHADY RETREAT ROAD DOYLESTOWN PA 18901
Business Address 621 N. SHADY RETREAT ROAD DOYLESTOWN PA 18901 2153450919
ProPhase Labs, Inc. (Filer) CIK: 0000868278 (see all company filings)

IRS No.: 232577138 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-21617 | Film No.: 17637182
SIC: 2834 Pharmaceutical Preparations